ArticleThe Journal of clinical investigation2020

GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.

Jing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.